52-Week High Stock – ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC 52 Week High Stock price of Thursday Trading Session at $0.02

On March 14 Shares of ImmunoCellular Therapeutics, Ltd. (IMUC) were valued at $0.02 and moved 0.00% as of a recent closing trade. A total volume of 0.01 million shares were traded versus to average volume of 0.22 million shares.


ImmunoCellular Therapeutics, Ltd. (IMUC) held 41.91 million outstanding shares currently. The company have shares float of 41.81 million. Now have a look at past performance (weekly performance to year to date performance) how ImmunoCellular Therapeutics, Ltd. (IMUC) has been moved; whether it performed well or not. IMUC reported a change of -0.40% over the last week and performed -11.07% over the last month while its year to date (YTD) performance revealed an activity trend of 46.47%. The stock’s quarterly performance specifies a shift of -11.07%, and its last twelve month performance is stands at -92.31% while moved -89.40% for the past six months.

Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. IMUC recently closed with fall of -1.44% to its twenty-Day SMA. This short time frame picture represents a downward movement of current price over average price of last twenty days.

52 week High and Low

ImmunoCellular Therapeutics, Ltd. (IMUC) shares have been seen trading -92.19% off its 52 week- peak value and changed 77.86% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.

Analysts have suggested a mean rating of 3.00 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

Relative Strength Index (RSI)

ImmunoCellular Therapeutics, Ltd. (IMUC)’s Relative Strength Index (RSI) is 48.95. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for ImmunoCellular Therapeutics, Ltd. (IMUC) is stands at 0.00. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.

Over the past week, the company showed volatility of 19.39%. Moving out to look at the previous month volatility move, the stock is at 19.93%.

Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is -0.31.


Kenneth Wysocki covers the Services Sector of Wallstreetmorning.com. He has over 5 years experience writing services and business news. He is a graduate of the University of Florida graduating with an MBA. He focuses on adding value to shareholders' portfolios via thoroughly checked proprietary information and data sources. He has a very strong interest in stock trading, and other various investments. He presently lives in Fort Myers, FL with his wife Heidi.

Leave a Reply

Your email address will not be published. Required fields are marked *